STERIS Corp. Reaches New 52-Week High at $55.39 (STE)
STERIS Corp. (NYSE:STE) shares hit a new 52-week high during trading on Thursday , American Banking & Market News reports. The company traded as high as $55.39 and last traded at $55.35, with a volume of 85,139 shares changing hands. The stock had previously closed at $55.00.
The stock’s 50-day moving average is $53.05 and its 200-day moving average is $50.35. The company has a market cap of $3.291 billion and a price-to-earnings ratio of 26.96.
STERIS Corp. (NYSE:STE) last announced its earnings results on Tuesday, August 5th. The company reported $0.54 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.54. The company had revenue of $412.60 million for the quarter, compared to the consensus estimate of $418.26 million. During the same quarter in the previous year, the company posted $0.44 earnings per share. The company’s revenue for the quarter was up 12.2% on a year-over-year basis. On average, analysts predict that STERIS Corp. will post $2.86 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which is scheduled for Tuesday, September 23rd. Stockholders of record on Tuesday, August 26th will be paid a dividend of $0.23 per share. This represents a $0.92 annualized dividend and a dividend yield of 1.66%. The ex-dividend date is Friday, August 22nd. This is a boost from STERIS Corp.’s previous quarterly dividend of $0.21.
In other STERIS Corp. news, Director Michael B. Wood sold 5,300 shares of the company’s stock on the open market in a transaction that occurred on Monday, August 11th. The stock was sold at an average price of $51.79, for a total transaction of $274,487.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.
STERIS Corporation (NYSE:STE) is a provider of infection prevention and surgical products and services, focused on healthcare, pharmaceutical and research.
Receive News & Ratings for STERIS Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.